Importance In patients with severe community-acquired pneumonia, treatment failure is
associated with excessive inflammatory response and worse outcomes. Corticosteroids may …

Background The distribution of the microbial aetiology and mortality of community-acquired
pneumonia (CAP) was investigated in relation to the clinical setting and severity scores (…

Background Prolonged life expectancy has currently increased the proportion of the very
elderly among patients with community-acquired pneumonia (CAP). The aim of this study was …

Background Our aim was to evaluate the benefits and harms of adjunctive corticosteroids in
adults hospitalized with community-acquired pneumonia (CAP) using individual patient data …

Introduction The frequency and clinical significance of polymicrobial aetiology in community-acquired
pneumonia (CAP) patients admitted to the ICU have been poorly studied. The aim …

Background: It is crucial to identify risk factors for poor evolution of patients admitted to
hospital with chronic obstructive pulmonary disease (COPD) in order to provide adequate …

Objective Pseudomonas aeruginosa often presents multi-drug resistance (MDR) in intensive
care unit (ICU)-acquired pneumonia (ICUAP), possibly resulting in inappropriate empiric …

Background and Objective Twenty per cent of chronic obstructive pulmonary disease (COPD)
patients are readmitted for acute exacerbation (AECOPD) within 30 days of discharge. The …

Background Pseudomonas aeruginosa is not a frequent pathogen in community-acquired
pneumonia (CAP). However, in patients with severe CAP, P aeruginosa can be the etiology in …

The purpose of this study was to establish the microbial aetiology and outcomes of patients
with community-acquired pneumonia (CAP) treated as outpatients after presenting to a …